文献速递神经肿瘤

胶质瘤相关巨噬细胞和小胶质细胞的免疫生物学:功能与治疗意义

Immune biology of glioma-associated macrophages and microglia: functional and therapeutic implications.
PubMed 文献 · Neuro Oncol · 2020-01-01

本文综述中枢神经系统免疫防御由脑内驻留巨噬细胞和小胶质细胞主导,这些髓系细胞在胶质瘤中占细胞总量的30-50%,具有异质性亚群和时空特异性表型。文章讨论了胶质瘤相关巨噬细胞和小胶质细胞的身份、募集分子驱动因素、命名与功能悖论、治疗重编程与极化策略、相关挑战及治疗调控观点。

要点

  • 脑内驻留巨噬细胞和小胶质细胞是中枢神经系统先天免疫哨兵和前线宿主免疫屏障。
  • 髓系细胞是胶质瘤中主要免疫群体,可占细胞总量的30-50%。
  • 实质小胶质细胞和外周募集单核来源巨噬细胞具疾病特异性表型、时空差异和分子特征异质性。

核心结论

  • 胶质瘤相关巨噬细胞和小胶质细胞免疫生物学涉及身份、募集分子驱动、命名与功能悖论、治疗重编程与极化策略及相关挑战。

研究设计与样本

  • 综述,检索范围原文未报告。

主要发现

  • 脑内驻留巨噬细胞和小胶质细胞是中枢神经系统先天免疫哨兵和前线宿主免疫屏障。
  • 髓系细胞是胶质瘤中主要免疫群体,可占细胞总量的30-50%。
  • 实质小胶质细胞和外周募集单核来源巨噬细胞具疾病特异性表型、时空差异和分子特征异质性。
  • 中枢神经系统炎症(包括胶质瘤)中髓系细胞多于淋系细胞,是脑免疫与外周免疫的对比特征。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CNS immune defenses are marshaled and dominated by brain resident macrophages and microglia, which are the innate immune sentinels and frontline host immune barriers against various pathogenic insults. These myeloid lineage cells are the predominant immune population in gliomas and can constitute up to 30-50% of the total cellular composition. Parenchymal microglial cells and recruited monocyte-derived macrophages from the periphery exhibit disease-specific phenotypic characteristics with spatial and temporal distinctions and are heterogeneous subpopulations based on their molecular signatures. A preponderance of myeloid over lymphoid lineage cells during CNS inflammation, including gliomas, is a contrasting feature of brain immunity relative to peripheral immunity. Herein we discuss glioma-associated macrophage and microglia immune biology in the context of their identity, molecular drivers of recruitment, nomenclature and functional paradoxes, therapeutic reprogramming and polarization strategies, relevant challenges, and our perspectives on therapeutic modulation.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Wei J, Chen P, Gupta P, et al. Immune biology of glioma-associated macrophages and microglia: functional and therapeutic implications. Neuro Oncol. 2020. PMID: 31679017. doi:10.1093/neuonc/noz212

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。